Literature DB >> 33248719

Letter to the editor: The placenta and COVID-19.

Rasha A Al-Lami1, Ammar M A Algburi2.   

Abstract

Entities:  

Keywords:  COVID-19; Maternal-fetal interface; Placenta; SARS-CoV-2

Year:  2020        PMID: 33248719      PMCID: PMC7672360          DOI: 10.1016/j.placenta.2020.11.007

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


× No keyword cloud information.
Angiotensin-converting enzyme type-2 Corona Virus Infectious Disease Severe acute respiratory syndrome coronavirus 2 Komine-Aizawa et al. [1] recommended further examination of placental tissues from delivering mothers with COVID-19. In fact, examining tissues of maternal-fetal interface and placenta specimens from COVID-19 patients would provide more understanding about COVID-19 pathology in pregnant women, possible vertical transmission and therapeutic modalities for COVID-19. ACE 2 receptors, that SARS-CoV-2 mainly uses to enter the cell, are expressed on tissues of the maternal-fetal interface (comprised of maternally derived decidua and fetally derived placenta) which might indicate a possibility of SARS-CoV-2 vertical transmission [2]. Although COVID-19 vertical transmission is controversial, there is evidence behind it [3]. Moreover, it has been demonstrated that uterine contraction and fetal demise are possible once uterine ACE 2 receptors are knocked out [4]. This may explain why some COVID-19 pregnant women have preterm deliveries and miscarriages [5]. Whether ACE 2 receptor play a role in SARS-CoV-2 possible vertical transmission and/or maternal morbidity need to be further investigated by examining tissues of maternal-fetal interface including placenta. Furthermore, understanding the immunity of the maternal-fetal interface is imperative to speculate potential therapeutic modalities for COVID-19 patients. Cultured Human Placental Trophoblast cells showed resistance to number of RNA and DNA viruses [6]. This resistance was conferred to non-placental tissues which subsequently exhibited reduced viral replication by autophagy (self-eating) mechanism [6]. In addition, autophagy, can attenuate the inflammatory cascade that may accompany the pathogen infection [7]. Added together, meticulously studying the placental immunity might provide novel therapeutic strategies to viral and inflammatory diseases like COVID-19.

Informed consent

N/A.

Author contributions

Both Rasha Al-Lami and Ammar Algburi discussed Komine-Aizawa et al findings and participated in drafting and editing this manuscript.

Declaration of competing interest

None.
  4 in total

1.  Uterine artery dysfunction in pregnant ACE2 knockout mice is associated with placental hypoxia and reduced umbilical blood flow velocity.

Authors:  Liliya M Yamaleyeva; Victor M Pulgar; Sarah H Lindsey; Larissa Yamane; Jasmina Varagic; Carolynne McGee; Mauro daSilva; Paula Lopes Bonfa; Susan B Gurley; K Bridget Brosnihan
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-05-12       Impact factor: 4.310

2.  Human placental trophoblasts confer viral resistance to recipient cells.

Authors:  Elizabeth Delorme-Axford; Rogier B Donker; Jean-Francois Mouillet; Tianjiao Chu; Avraham Bayer; Yingshi Ouyang; Tianyi Wang; Donna B Stolz; Saumendra N Sarkar; Adrian E Morelli; Yoel Sadovsky; Carolyn B Coyne
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-01       Impact factor: 11.205

Review 3.  Autophagy in infection, inflammation and immunity.

Authors:  Vojo Deretic; Tatsuya Saitoh; Shizuo Akira
Journal:  Nat Rev Immunol       Date:  2013-10       Impact factor: 53.106

Review 4.  Coronavirus in pregnancy and delivery: rapid review.

Authors:  E Mullins; D Evans; R M Viner; P O'Brien; E Morris
Journal:  Ultrasound Obstet Gynecol       Date:  2020-05       Impact factor: 7.299

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.